カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場予測2023-2029：5mg錠、50mg錠

【英語タイトル】Dolutegravir and Dolutegravir Generic Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8479）・商品コード：MMG23LY8479
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：76
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場規模と予測を収録しています。・世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：売上、2018年-2023年、2024年-2029年
・世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「5mg錠」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ドルテグラビル＆ドルテグラビルジェネリック医薬品のグローバル主要企業は、ViiV Healthcare Pty Ltd、 Emcure Pharmaceuticals、 Mylan、 Aurobindo Pharma、 Qilu Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ドルテグラビル＆ドルテグラビルジェネリック医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：タイプ別市場シェア、2022年
・5mg錠、50mg錠

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：用途別、2018年-2023年、2024年-2029年
世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：用途別市場シェア、2022年
・子供、大人

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるドルテグラビル＆ドルテグラビルジェネリック医薬品のグローバル売上、2018年-2023年
・主要企業におけるドルテグラビル＆ドルテグラビルジェネリック医薬品のグローバル売上シェア、2022年
・主要企業におけるドルテグラビル＆ドルテグラビルジェネリック医薬品のグローバル販売量、2018年-2023年
・主要企業におけるドルテグラビル＆ドルテグラビルジェネリック医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
ViiV Healthcare Pty Ltd、 Emcure Pharmaceuticals、 Mylan、 Aurobindo Pharma、 Qilu Pharmaceutical

*************************************************************

・調査・分析レポートの概要
ドルテグラビル＆ドルテグラビルジェネリック医薬品市場の定義
市場セグメント
世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場規模
世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場規模：2022年 VS 2029年
世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのドルテグラビル＆ドルテグラビルジェネリック医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のドルテグラビル＆ドルテグラビルジェネリック医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：5mg錠、50mg錠
ドルテグラビル＆ドルテグラビルジェネリック医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：子供、大人
ドルテグラビル＆ドルテグラビルジェネリック医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別ドルテグラビル＆ドルテグラビルジェネリック医薬品市場規模 2022年と2029年
地域別ドルテグラビル＆ドルテグラビルジェネリック医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
ViiV Healthcare Pty Ltd、 Emcure Pharmaceuticals、 Mylan、 Aurobindo Pharma、 Qilu Pharmaceutical
...

This report aims to provide a comprehensive presentation of the global market for Dolutegravir and Dolutegravir Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir and Dolutegravir Generic Drugs. This report contains market size and forecasts of Dolutegravir and Dolutegravir Generic Drugs in global, including the following market information:
Global Dolutegravir and Dolutegravir Generic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dolutegravir and Dolutegravir Generic Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dolutegravir and Dolutegravir Generic Drugs companies in 2022 (%)
The global Dolutegravir and Dolutegravir Generic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
5mg Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dolutegravir and Dolutegravir Generic Drugs include ViiV Healthcare Pty Ltd, Emcure Pharmaceuticals, Mylan, Aurobindo Pharma and Qilu Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dolutegravir and Dolutegravir Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dolutegravir and Dolutegravir Generic Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dolutegravir and Dolutegravir Generic Drugs Market Segment Percentages, by Type, 2022 (%)
5mg Tablets
50mg Tablets
Global Dolutegravir and Dolutegravir Generic Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dolutegravir and Dolutegravir Generic Drugs Market Segment Percentages, by Application, 2022 (%)
Children
Adult
Global Dolutegravir and Dolutegravir Generic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dolutegravir and Dolutegravir Generic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dolutegravir and Dolutegravir Generic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dolutegravir and Dolutegravir Generic Drugs revenues share in global market, 2022 (%)
Key companies Dolutegravir and Dolutegravir Generic Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dolutegravir and Dolutegravir Generic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare Pty Ltd
Emcure Pharmaceuticals
Mylan
Aurobindo Pharma
Qilu Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dolutegravir and Dolutegravir Generic Drugs, market overview.
Chapter 2: Global Dolutegravir and Dolutegravir Generic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Dolutegravir and Dolutegravir Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dolutegravir and Dolutegravir Generic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dolutegravir and Dolutegravir Generic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dolutegravir and Dolutegravir Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dolutegravir and Dolutegravir Generic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dolutegravir and Dolutegravir Generic Drugs Overall Market Size
2.1 Global Dolutegravir and Dolutegravir Generic Drugs Market Size: 2022 VS 2029
2.2 Global Dolutegravir and Dolutegravir Generic Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dolutegravir and Dolutegravir Generic Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Dolutegravir and Dolutegravir Generic Drugs Players in Global Market
3.2 Top Global Dolutegravir and Dolutegravir Generic Drugs Companies Ranked by Revenue
3.3 Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Companies
3.4 Global Dolutegravir and Dolutegravir Generic Drugs Sales by Companies
3.5 Global Dolutegravir and Dolutegravir Generic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dolutegravir and Dolutegravir Generic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dolutegravir and Dolutegravir Generic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dolutegravir and Dolutegravir Generic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Dolutegravir and Dolutegravir Generic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Dolutegravir and Dolutegravir Generic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Market Size Markets, 2022 & 2029
4.1.2 5mg Tablets
4.1.3 50mg Tablets
4.2 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue & Forecasts
4.2.1 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2023
4.2.2 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2024-2029
4.2.3 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales & Forecasts
4.3.1 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2023
4.3.2 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2024-2029
4.3.3 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adult
5.2 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue & Forecasts
5.2.1 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2023
5.2.2 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2024-2029
5.2.3 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales & Forecasts
5.3.1 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2023
5.3.2 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2024-2029
5.3.3 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Market Size, 2022 & 2029
6.2 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue & Forecasts
6.2.1 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2023
6.2.2 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2024-2029
6.2.3 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales & Forecasts
6.3.1 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2023
6.3.2 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2024-2029
6.3.3 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.4.2 By Country – North America Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.4.3 US Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.4.4 Canada Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.4.5 Mexico Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.5.3 Germany Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.4 France Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.5 U.K. Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.6 Italy Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.7 Russia Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.9 Benelux Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.6.3 China Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.4 Japan Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.5 South Korea Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.7 India Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.7.2 By Country – South America Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.7.3 Brazil Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.7.4 Argentina Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.8.3 Turkey Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8.4 Israel Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8.6 UAE Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ViiV Healthcare Pty Ltd
7.1.1 ViiV Healthcare Pty Ltd Company Summary
7.1.2 ViiV Healthcare Pty Ltd Business Overview
7.1.3 ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.1.4 ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 ViiV Healthcare Pty Ltd Key News & Latest Developments
7.2 Emcure Pharmaceuticals
7.2.1 Emcure Pharmaceuticals Company Summary
7.2.2 Emcure Pharmaceuticals Business Overview
7.2.3 Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.2.4 Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Emcure Pharmaceuticals Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.3.4 Mylan Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Company Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.4.4 Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Aurobindo Pharma Key News & Latest Developments
7.5 Qilu Pharmaceutical
7.5.1 Qilu Pharmaceutical Company Summary
7.5.2 Qilu Pharmaceutical Business Overview
7.5.3 Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.5.4 Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Qilu Pharmaceutical Key News & Latest Developments
8 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity, Analysis
8.1 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity, 2018-2029
8.2 Dolutegravir and Dolutegravir Generic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Dolutegravir and Dolutegravir Generic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dolutegravir and Dolutegravir Generic Drugs Supply Chain Analysis
10.1 Dolutegravir and Dolutegravir Generic Drugs Industry Value Chain
10.2 Dolutegravir and Dolutegravir Generic Drugs Upstream Market
10.3 Dolutegravir and Dolutegravir Generic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dolutegravir and Dolutegravir Generic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dolutegravir and Dolutegravir Generic Drugs in Global Market
Table 2. Top Dolutegravir and Dolutegravir Generic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Dolutegravir and Dolutegravir Generic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dolutegravir and Dolutegravir Generic Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Dolutegravir and Dolutegravir Generic Drugs Product Type
Table 9. List of Global Tier 1 Dolutegravir and Dolutegravir Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dolutegravir and Dolutegravir Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 46. ViiV Healthcare Pty Ltd Company Summary
Table 47. ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 48. ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. ViiV Healthcare Pty Ltd Key News & Latest Developments
Table 50. Emcure Pharmaceuticals Company Summary
Table 51. Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 52. Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Emcure Pharmaceuticals Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 56. Mylan Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. Aurobindo Pharma Company Summary
Table 59. Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 60. Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Aurobindo Pharma Key News & Latest Developments
Table 62. Qilu Pharmaceutical Company Summary
Table 63. Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 64. Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Qilu Pharmaceutical Key News & Latest Developments
Table 66. Dolutegravir and Dolutegravir Generic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Dolutegravir and Dolutegravir Generic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Dolutegravir and Dolutegravir Generic Drugs Production by Region, 2018-2023 (K Units)
Table 69. Global Dolutegravir and Dolutegravir Generic Drugs Production by Region, 2024-2029 (K Units)
Table 70. Dolutegravir and Dolutegravir Generic Drugs Market Opportunities & Trends in Global Market
Table 71. Dolutegravir and Dolutegravir Generic Drugs Market Drivers in Global Market
Table 72. Dolutegravir and Dolutegravir Generic Drugs Market Restraints in Global Market
Table 73. Dolutegravir and Dolutegravir Generic Drugs Raw Materials
Table 74. Dolutegravir and Dolutegravir Generic Drugs Raw Materials Suppliers in Global Market
Table 75. Typical Dolutegravir and Dolutegravir Generic Drugs Downstream
Table 76. Dolutegravir and Dolutegravir Generic Drugs Downstream Clients in Global Market
Table 77. Dolutegravir and Dolutegravir Generic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dolutegravir and Dolutegravir Generic Drugs Segment by Type in 2022
Figure 2. Dolutegravir and Dolutegravir Generic Drugs Segment by Application in 2022
Figure 3. Global Dolutegravir and Dolutegravir Generic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dolutegravir and Dolutegravir Generic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Dolutegravir and Dolutegravir Generic Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dolutegravir and Dolutegravir Generic Drugs Revenue in 2022
Figure 9. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 23. US Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 28. Germany Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 37. China Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dolutegravir and Dolutegravir Generic Drugs by Region, 2022 VS 2029
Figure 54. Dolutegravir and Dolutegravir Generic Drugs Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場予測2023-2029：5mg錠、50mg錠] (コード：MMG23LY8479)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場予測2023-2029：5mg錠、50mg錠]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場2022年：5mg錠、50mg錠
  • 世界のバルデナフィル市場2022年：2.5mg錠、5mg錠、10mg錠、20mg錠
  • 世界の経口型タダラフィル市場2022年：2.5mg錠、5mg錠、10mg錠、20mg錠
  • 世界のアルフゾシン市場2022年：2.5mg錠、10mg錠
  • 世界のソリフェナシンコハク酸塩製剤市場2022年：5mg錠、10mg錠

    • ◆H&Iグローバルリサーチのお客様（例）◆